KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Net Margin for 4 consecutive years, with 546.44% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Net Margin rose 46283.0% year-over-year to 546.44%, compared with a TTM value of 412.03% through Dec 2023, up 2848.0%, and an annual FY2024 reading of 581945.74%, down 37812845.0% over the prior year.
  • Net Margin was 546.44% for Q3 2023 at Ginkgo Bioworks Holdings, down from 215.12% in the prior quarter.
  • Across five years, Net Margin topped out at 10078.14% in Q4 2020 and bottomed at 1170.92% in Q4 2021.
  • Average Net Margin over 4 years is 398.81%, with a median of 253.98% recorded in 2023.
  • The sharpest move saw Net Margin plummeted -1124905bps in 2021, then skyrocketed 99482bps in 2022.
  • Year by year, Net Margin stood at 10078.14% in 2020, then tumbled by -112bps to 1170.92% in 2021, then surged by 85bps to 176.1% in 2022, then tumbled by -210bps to 546.44% in 2023.
  • Business Quant data shows Net Margin for DNA at 546.44% in Q3 2023, 215.12% in Q2 2023, and 253.98% in Q1 2023.